Radiation exposures of cancer patients from medical X-rays: how relevant are they for individual patients and population exposure?

[1]  N. Weid,et al.  Adult life after surviving lymphoma in childhood , 2008, Supportive Care in Cancer.

[2]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[3]  S. Bentzen,et al.  Evaluation of early and late toxicities in chemoradiation trials. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Ezekiel J Emanuel,et al.  Risks and benefits associated with novel phase 1 oncology trial designs , 2007, Cancer.

[5]  Zongguang Zhou,et al.  The Effectiveness of Intravenous 5-Fluorouracil-Containing Chemotherapy after Curative Resection for Gastric Carcinoma: A Systematic Review of Published Randomized Controlled Trials , 2007, Journal of chemotherapy.

[6]  C. Beyan,et al.  The effect of radiologic imaging studies on the risk of secondary malignancy development in patients with Hodgkin lymphoma. , 2007, Clinical lymphoma & myeloma.

[7]  Michael J Pentecost,et al.  American College of Radiology white paper on radiation dose in medicine. , 2007, Journal of the American College of Radiology : JACR.

[8]  L. Travis,et al.  The Epidemiology of Second Primary Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[9]  T. Ohno,et al.  Risk of second cancers after radiotherapy for cervical cancer , 2006, Expert review of anticancer therapy.

[10]  Robert A. Israel,et al.  International Classification of Diseases (ICD) , 2005 .

[11]  G. Brix,et al.  Assessment of a theoretical formalism for dose estimation in CT: an anthropomorphic phantom study , 2004, European Radiology.

[12]  K. Nishizawa,et al.  [Survey of CT practice in Japan and collective effective dose estimation]. , 2004, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[13]  Amy Berrington de González,et al.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries , 2004, The Lancet.

[14]  E. Ron,et al.  CANCER RISKS FROM MEDICAL RADIATION , 2003, Health physics.

[15]  J. Coebergh,et al.  Cancer prevalence in Central Europe: the EUROPREVAL Study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  H. Nagel,et al.  CT-Expo - ein neuartiges Programm zur Dosisevaluierung in der CT , 2002 .

[17]  岩崎 民子.  SOURCES AND EFFECTS OF IONIZING RADIATION : United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2000 Report to the General Assembly, with Scientific Annexes , 2002 .

[18]  N. Viñolas,et al.  Carboplatin, methotrexate, vinblastine and epirubicin (Carbo-MVE) for transitional cell bladder carcinoma. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  J. Buring,et al.  Epidemiology in Medicine , 1987 .

[20]  Health Risks from Exposure to Low Levels of Ionizing Radiation : BEIR VII Phase 2 4 / 10 / 2011 , 2011 .

[21]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .

[22]  B. Wall,et al.  Estimation of effective dose in diagnostic radiology from entrance surface dose and dose-area product measurements , 1994 .

[23]  Icrp.  1990 Recommendations of the International Commission on Radiological Protection , 1991 .